Genenta Science S.p.A. (GNTA) Balance Sheet

NASDAQ: GNTAAssets, liabilities, debt and equity over 7 years.

GNTA balance sheet, 2025

December 31, 2025 · euros

€31.9M assets = €10.0M liabilities + €21.8M equity

What it owns€31.9MCash & ST investments: €28.1M (88.3%)Cash & ST investments€28.1M · 88%Receivables: €1.3M (4.0%)Other current: €544,732 (1.7%)PP&E: €22,465 (0.1%)Other non-current: €1.9M (5.9%)Other non-current €1.9M=How it is financed€31.9MCurrent liabilities: €2.1M (6.6%)Current liabilities €2.1MLong-term debt: €7.6M (23.8%)Long-term debt€7.6M · 24%Other LT liabilities: €327,785 (1.0%)Shareholders’ equity: €21.8M (68.5%)Shareholders’ equity€21.8M · 68%

Both columns are drawn to the same scale: what GNTA owns equals what it owes plus shareholders’ equity. Hover a block for its value.

GNTA financial health

Debt / equity0.35
Low leverage · €0.35 of debt for each $1 of equity
Equity / assets68.5%
Equity-funded · of assets funded by shareholders
Cash / debt370.2%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

GNTA balance sheet trends, 2019–2025

MetricTrendThenLatestChange
Total assets€21.3M2019€31.9M2025+6.9%/yr
Total liabilities€2.5M2019€10.0M2025+26.1%/yr
Shareholders’ equity€18.9M2019€21.8M2025+2.5%/yr
Cash & short-term investments€20.1M2019€28.1M2025+5.7%/yr
Total debt€152023€7.6M2025+72,088.0%/yr
Net cash (debt)€18.8M2023€20.5M2025+€1.8M
Working capital€18.1M2019€27.9M2025+€9.7M
Debt / equity0.0020230.352025+0.35
Shares outstanding18.1M201919.7M2025+1.4%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

GNTA assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

GNTA liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

GNTA debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

GNTA balance sheet in euros

2025202420232022202120202019
Assets
Cash & short-term investments€28.1M€12.7M€18.8M€29.8M€37.2M€15.5M€20.1M
Cash & equivalents€5.5M€4.6M€3.7M€29.8M€37.2M€15.5M€20.1M
Short-term investments€22.6M€8.1M€15.1M€0€0——
Receivables€1.3M€1.4M€2.0M€1.6M€1.4M€760,631€429,589
Inventory€0€0€2€144,689€76,256€27,671−€163,491
Other current assets€544,732€364,815€476,918€219,400€21,987€280,631€192,020
Total current assets€30.0M€14.5M€21.3M€31.7M€38.8M€16.5M€20.6M
Property, plant & equipment (net)€22,465€42,922€57,033€111,639€23,090€18,971€0
Goodwill & intangible assets€0€87,800€18,488€88€0€0€0
Long-term investments€0€0€0€0€0€0€0
Other non-current assets€1.9M€220,294€1.0M€1.6M€1.2M€948,968€748,681
Total assets€31.9M€14.8M€22.3M€33.4M€40.0M€17.5M€21.3M
Liabilities
Accounts payable€1.5M€317,830€294,975€1.2M€189,866€555,015€572,440
Short-term debt—€13,400—————
Total current liabilities€2.1M€2.1M€1.7M€2.2M€1.1M€2.3M€2.5M
Long-term debt€7.6M€0€0€0€0€0€0
Other long-term liabilities€327,785€228,925€179,249€116,181€30,618€17,388€11,332
Total liabilities€10.0M€2.3M€1.9M€2.3M€1.2M€2.4M€2.5M
Shareholders' equity
Common stock & paid-in capital€84.3M€68.5M€67.3M€66.6M€65.9M€37,056€36,049
Retained earnings (deficit)−€62.6M−€56.1M−€47.1M−€35.5M−€27.0M−€21.5M−€15.9M
Accumulated other comprehensive income€166,511€88,946€231,142——€0€0
Total shareholders' equity€21.8M€12.5M€20.4M€31.1M€38.9M€15.2M€18.9M
Key figures
Total debt€7.6M€14,600€15————
Net cash (debt)€20.5M€12.6M€18.8M————
Working capital€27.9M€12.4M€19.5M€29.5M€37.6M€14.2M€18.1M
Tangible book value€21.8M€12.4M€20.4M€31.1M€38.9M€15.2M€18.9M
Shares outstanding19.7M18.3M18.2M18.2M18.2M18.1M18.1M
Current ratio14.166.8912.2514.5334.157.098.29
Quick ratio13.906.7211.9714.3634.066.958.27
Debt / equity0.350.000.00————
Equity / assets68.5%84.3%91.4%93.1%97.1%86.6%88.3%

Quarterly columns are labeled by the month the quarter ended. Figures in euros as reported (latest annual report filed April 1, 2026); data from EODHD.

GNTA financial position

At the end of fiscal 2025 (December 31, 2025), Genenta Science S.p.A. had total assets of €31.9 million (up 115.1% from a year earlier), total liabilities of €10.0 million and shareholders' equity of €21.8 million. It held €28.1 million in cash and short-term investments against €7.6 million of debt, a net cash position of €20.5 million. Its current ratio was 14.16. In the latest quarter (ended March 31, 2026) total assets were €31.9 million and equity €21.8 million.

Related: GNTA income statement, GNTA cash flow statement, GNTA key metrics. See the GNTA stock overview for the latest quote and news.

GNTA balance sheet FAQ

What are Genenta Science S.p.A.'s total assets?

Genenta Science S.p.A. reported total assets of €31.9 million at the end of fiscal 2025 (December 31, 2025), compared with €14.8 million a year earlier.

How much debt does Genenta Science S.p.A. have?

Genenta Science S.p.A. had €7.6 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.35.

How much cash does Genenta Science S.p.A. have?

Genenta Science S.p.A. held €28.1 million in cash and short-term investments at the end of fiscal 2025; with €7.6 million of debt that is net cash of €20.5 million.

What is Genenta Science S.p.A.'s book value?

Genenta Science S.p.A.'s shareholders' equity (book value) was €21.8 million at the end of fiscal 2025.

What is Genenta Science S.p.A.'s current ratio?

Genenta Science S.p.A. had current assets of €30.0 million and current liabilities of €2.1 million, a current ratio of 14.16 (it can cover its short-term obligations).

Conglomerates: balance sheet